Smart Responsive Antimicrobial Implants
Lead Participant:
T.J.SMITH AND NEPHEW,LIMITED
Abstract
The primary objective of this collaborative research project is to develop a smart antimicrobial orthopaedic implant suitable for mass production in the established and emerging markets. The 3yr project is industry led by a global medical device company (Smith and Nephew) collaborating with a charitable NHS hospital trust and
academia. The antimicrobial technology developed herein will help reduce the global threat of anti-microbial resistance and level of bioburden experienced in trauma by improving the aseptic conditions during surgery. The primary output of this project will be a demonstrator suitable for first in man/clinical trials, and a platform technology, which is applicable in other healthcare and industrial sectors given its high level of innovation..
academia. The antimicrobial technology developed herein will help reduce the global threat of anti-microbial resistance and level of bioburden experienced in trauma by improving the aseptic conditions during surgery. The primary output of this project will be a demonstrator suitable for first in man/clinical trials, and a platform technology, which is applicable in other healthcare and industrial sectors given its high level of innovation..
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| T.J.SMITH AND NEPHEW,LIMITED | £372,753 | £ 186,377 |
Participant |
||
| SMITH & NEPHEW UK LIMITED | £273,627 | £ 136,814 |
| NOTTINGHAM UNIVERSITY HOSPITAL | £14,828 | £ 14,828 |
| UNIVERSITY OF NOTTINGHAM | £137,572 | £ 137,572 |
| THE RUSSELL GROUP OF UNIVERSITIES | £145,761 | £ 145,761 |
People |
ORCID iD |
| Darren Wilson (Project Manager) |